Muharrem Ergun DUDAK | Oral Surgery | Best Researcher Award

Posted on by Neuroscientists

Dr. Muharrem Ergun DUDAK | Oral Surgery | Best Researcher Award

Dr.  Muharrem Ergun DUDAK,  Ege University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery,  Turkey.

Muharrem Ergun Dudak is a dedicated researcher and surgeon in the field of oral and maxillofacial surgery, specializing in implantology and TMJ disorders. He began his academic journey at Ege University Faculty of Dentistry, graduating in 2016, and later pursued specialization in maxillofacial surgery, which he successfully completed in 2023. Currently, he continues his academic and professional work at Ege University, contributing to both clinical advancements and research. His expertise and contributions have earned him recognition, including a nomination for the Best Researcher Award. He is actively involved in professional organizations, consultancy projects, and academic publications, influencing the future of maxillofacial surgery.

Profile

orcid

Early Academic Pursuits 📚

Muharrem Ergun Dudak embarked on his journey in the field of dentistry with a strong academic foundation. He was admitted to Ege University Faculty of Dentistry in 2011, where he honed his skills and developed a keen interest in oral and maxillofacial surgery. His dedication and perseverance led him to successfully complete his degree in 2016, marking the beginning of an illustrious career in dental research and surgery.

Professional Endeavors 🏥

Following his graduation, he took the Dentistry Specialization Examination, which paved the way for his appointment as a researcher in the Department of Oral and Maxillofacial Surgery at Ege University in 2018. His commitment to advancing surgical techniques and patient care led him to specialize in this field, achieving his specialization in 2023. Today, he continues to contribute as a dedicated academic and surgeon at Ege University, shaping the future of maxillofacial surgery through both practice and research.

Contributions and Research Focus 🔍

Muharrem Ergun Dudak has focused his research on oral and maxillofacial surgery, implantology, and temporomandibular joint (TMJ) disorders. His work aims to improve patient outcomes through advanced surgical techniques and innovative treatment methods. His participation in multiple professional organizations, including EACMFS, ACBID, and TAOMS, reflects his commitment to staying at the forefront of surgical advancements and interdisciplinary collaborations.

Accolades and Recognition 🏆

His dedication to research and clinical excellence has earned him prestigious recognitions, including a nomination for the Best Researcher Award. His contributions to academic literature and specialized surgical fields have positioned him as a rising figure in maxillofacial surgery. His publications and citation index further showcase his influence in shaping modern dental and surgical practices.

Impact and Influence 🌍

Through his work, Muharrem Ergun Dudak has significantly contributed to the understanding and treatment of maxillofacial conditions. His research has impacted both clinical applications and academic advancements, bridging the gap between theory and practice. His involvement in consultancy projects and editorial boards adds another layer to his influence, guiding young professionals and fellow researchers toward innovation.

Legacy and Future Contributions 🔮

With an ever-growing passion for maxillofacial research and education, he envisions a future where his work leads to groundbreaking treatments for TMJ disorders and advanced dental implantology. His commitment to academic excellence ensures that he will continue to mentor, innovate, and contribute to the field, inspiring the next generation of dental surgeons and researchers.Muharrem Ergun Dudak stands as a beacon of dedication and expertise, striving to push the boundaries of oral and maxillofacial surgery with each passing year.

Publication

Title: Safe Dental Care During COVID-19 Pandemic
Authors: Bengü Erden Şahin, Neslihan Efeoglu, Ergün Dudak, Candan Efeoğlu
Year: 2020

Conclusion 🎯

With a strong foundation in research and clinical practice, Muharrem Ergun Dudak is shaping the future of dental and maxillofacial surgery. His work not only advances surgical techniques but also bridges the gap between research and patient care. As he continues to innovate and mentor, his impact on dentistry and surgical sciences is set to grow, ensuring that his contributions will benefit future generations of researchers and practitioners.

Hui-Hsin Ko | Oral oncology | Best Researcher Award

Posted on by Neuroscientists

Dr. Hui-Hsin Ko | Oral oncology | Best Researcher Award

Dr . Hui-Hsin Ko National Taiwan University Hsin-Chu Hospital Taiwan

Dr. Hui-Hsin Ko is an Assistant Professor and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hsin-Chu Hospital. With a DDS, MS, and PhD from National Taiwan University, she has extensive expertise in oral and maxillofacial surgery, specializing in cancer surgeries, temporomandibular joint (TMJ) surgeries, and zygomatic implantation. Dr. Ko’s research focuses on oral squamous cell carcinoma, with multiple publications in SCI-indexed journals. She has contributed significantly to the field of cancer research by exploring biomarkers such as AKR1B10, advancing both the understanding and treatment of oral cancers. Dr. Ko’s achievements in research and clinical practice have set a high standard for innovation in her field.

 

profile

scopus

Academic and Professional Background 🎓

Dr. Hui-Hsin Ko is a Clinical Assistant Professor at National Taiwan University and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hospital, Hsin-Chu Branch. She holds a DDS, MS, and PhD from National Taiwan University, with specialization in oral and maxillofacial surgery. Her expertise includes temporomandibular joint surgery, cancer surgery, and zygomatic implantation. A diplomate of the Taiwan Board of Oral and Maxillofacial Surgery, Dr. Ko has authored several publications, significantly contributing to oral squamous cell carcinoma research.

Research and Innovations 💡

Completed/Ongoing Research Projects: AKR1B10-related, TMJ arthroscopy-related, oral cancer-related.Citation Index: Information available on indexed platformsConsultancy/Industry Projects: To be updated Books Published (ISBN): No books published yet.Patents Published/Under Process: To be updated.Journals Published (SCI, Scopus, etc.): Multiple articles published in SCI-indexed journals

Editorial Appointments ✍️

To be updated.

Collaborations 🤝

Dr. Ko has actively collaborated with medical professionals and researchers in Taiwan to advance studies in oral squamous cell carcinoma and oral health-related surgeries.

Professional Memberships 📜

Diplomate of the Taiwan Board of Oral and Maxillofacial Surgery.Member of various oral and maxillofacial surgical associations

Areas of Research 🔬

Oral squamous cell carcinoma.Temporomandibular joint surgery.Zygomatic implantation.Cancer surgery

Contributions 🌟

Dr. Hui-Hsin Ko has significantly contributed to cancer research, especially in identifying biomarkers for oral squamous cell carcinoma progression. Her work on AKR1B10 levels has opened new pathways in understanding the poor prognosis of the disease. She has also explored advanced surgical techniques, including TMJ surgery and zygomatic implantation, contributing to improved patient outcomes.

 

📚 Publications

  • Title: The dental implant survival rate in 18 patients with post-operation revolutionary jaw reconstruction using free fibular flap, dental implants, and overdentures
    Author(s): Ko, H.-H., Chou, C.-H., Cheng, S.-J.
    Year: 2024

 

  • Title: Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma
    Author(s): Shie, W.-Y., Cheng, S.-J., Chen, K.-C., Hou, H.-H., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines
    Author(s): Ko, H.-H., Chou, H.-Y.E., Hou, H.-H., Yen-Ping Kuo, M., Cheng, S.-J.
    Year: 2024

 

  • Title: Prosthetic-Driven Autotransplantation with the Assistance of Medical Image-Processing Software and a Real-Time Navigation System: A Case Report
    Author(s): Chang, H.-M., Ko, H.-H., Chi, C.-W., Lin, I.-P., Chen, S.-H.
    Year: 2024

 

  • Title: Evaluation of the prognostic and therapeutic potential of inhibin beta B for oral squamous cell carcinoma
    Author(s): Chung, Y.-Y., Cheng, S.-J., Ko, H.-H., Shie, W.-Y., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP β-glucan in oral squamous cell carcinoma
    Author(s): Ko, H.-H., Peng, H.-H., Cheng, A.N., Lee, A.Y.-L., Cheng, S.-J.
    Year: 2023

 

  • Title: Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3
    Author(s): Lu, Y.-J., Deng, Y.-T., Ko, H.-H., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2023

 

  • Title: ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions
    Author(s): Juan, Y.-C., Su, Y.-F., Bai, C.-H., Fwu, C.-W., Cheng, S.-J.
    Year: 2023

 

  • Title: β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients
    Author(s): Lo, Y.-W., Lee, A.Y.-L., Liu, Y.-C., Chiang, C.-P., Cheng, S.-J.
    Year: 2022

 

  • Title: Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan
    Author(s): Peng, H.-H., Ko, H.-H., Chi, N.-C., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2020

 

Conclusion

Dr. Hui-Hsin Ko’s extensive background in oral and maxillofacial surgery, coupled with her impressive research contributions to the understanding of oral squamous cell carcinoma, makes her a strong candidate for the Best Researcher Award. Her dedication to advancing cancer research, her innovative surgical techniques, and her collaborative efforts in the medical field demonstrate her leadership and impact. Dr. Ko has not only excelled in her clinical practice but has also significantly contributed to scientific advancements that benefit patients globally.